MS, S.; Manjunath; PL, B.; KN, R.; Mukesh. A Prospective Randomised Open Label Study to Evaluate the Response Rate and Toxicity of Gefitinib in the Treatment of Carcinoma Cervix Patients on Chemoradiotherapy. J. Clin. Res. App. Med. 2022, 1, 59-62.